A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Mar 2018
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- Sponsors Bracco Diagnostics
- 19 Mar 2018 This trial has been completed in Germany (End Date; 2018-02-25).
- 11 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Feb 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.